Atlas Trials

Assessment of Rituximab Therapeutic Response Versus Conventional Treatment

Clinical trial NCT05553496 · UNKNOWN

Trial details

NCT number
NCT05553496
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pharmacological Action
Start date
2022-09-25
Primary completion
2023-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.